Glycemic Control in Critically Ill Patients Before and After Institution of an Intensive Insulin Infusion Protocol: Circadian Rhythm and the Quality Duration Calculator

Abstract

Introduction: A circadian rhythm of blood glucose values has been recently reported in critically ill patients, but there are no reports of how this rhythm is altered by a continuous intensive insulin infusion therapy protocol (IIT). We wished to examine the effect of IIT on this rhythm as well as to describe the use of the quality duration calculator (QDC) for the evaluation of glycemic control before and after IIT.

Methods: This was a retrospective multihospital observational study that took place in the medical and surgical intensive care units (ICUs) of 2 tertiary care hospitals. Cohorts of consecutively admitted critically ill patients from 2-year periods before and after institution of an IIT protocol were examined. Laboratory, demographic, and outcome data were extracted from hospital databases.

Results: We studied 167,645 blood glucose measurements from 8,327 patients. We observed a circadian rhythm of blood glucose control in the pre-IIT cohort that was greatly attenuated in the post-IIT cohort. The difference between the morning and the average daily blood glucose in the pre-IIT cohort was 3.53 mg/dL (P < .001), and the difference between these values in the post-IIT cohort was 1.10 mg/dL (P = .031). In addition, the circadian nature of hyperglycemia incidence observed in the pre-IIT cohort was not seen in the post-IIT cohort. The amount of time spent in goal glycemic range increased from 23.69% (95% CI 23.01-24.38) in the pre-IIT cohort to 29.67% (95% CI 29.04-30.31) in the post-IIT cohort as estimated by the QDC. The amount of time spent in the hyperglycemic decreased from 20.17% (95% CI 19.33-20.99) in the pre-IIT cohort to 14.80% (95% CI 14.15-15.39) in the post-IIT cohort.

Conclusions: The circadian rhythm of blood glucose control confirmed in our pre-IIT cohort was lost after institution of IIT. The morning blood glucose value appears to be a reasonable surrogate of overall glycemic control in a critically ill population on IIT, although this may vary based on the degree of control achieved. The QDC method is useful for analyzing glycemic control in patients on IIT.

Keywords

glycemic control hyperglycemia hypoglycemia insulin infusion protocol

Get full access to this article

View all access options for this article.

References

Van den Berghe G. , Wilmer A. , Hermans G. , et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.

Van den Berghe G. , Wouters P. , Weekers F. , et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19): 1359-1367.

Devos P. , Preiser JC Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? Crit Care. 2006;10(2):130.

Polderman KH , Girbes AR Intensive insulin therapy: of harm and health, of hypes and hypoglycemia. Crit Care Med. 2006; 34(1):246-248.

Braithwaite SS , Edkins R. , Macgregor KL , et al. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. Diabetes Technol Ther. 2006; 8(4):476-488.

Turina M. , Christ-Crain M. , Polk HC Jr. Diabetes and hyperglycemia: strict glycemic control. Crit Care Med. 2006;34(9 suppl): S291-S300.

Goldberg PA , Sakharova OV , Barrett PW , et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004;18(6):690-697.

Wilson M. , Weinreb J. , Hoo GW Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care. 2007;30(5): 1005-1011.

Egi M. , Bellomo R. , Stachowski E. , French CJ , Hart G. , Stow P. Circadian rhythm of blood glucose values in critically ill patients. Crit Care Med. 2007;35(2):416-421.

10.

Van den Berghe G. , Wouters PJ , Bouillon R. , et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-366.

11.

Hardin J. , Hilbe J. Generalized estimating equations. Boca Raton, FL: Chapman & Hall/CRC; 2003.

12.

Efron B. , Tibshirani RJ An introduction to the bootstrap. New York: Chapman & Hall; 1993.

13.

Bone EG , Young D. , Chantler J. Target ranges and the apparent compliance with tight glycaemic control. Anaesthesia. 2006; 61(10):956-958.

14.

Van den Berghe G. How to compare adequacy of algorithms to control blood glucose in the intensive care unit? Crit Care. 2004;8(3):151-152.

15.

De Block C. , Manuel-Y-Keeloy B. , Van Gaal L. , Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29(8): 1750-1756.

16.

Maran A. , Crepaldi C. , Tiengo A. , et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care. 2002 ;25(2):347-352.

17.

Vogelzang M. , van der Horst IC , Nijsten MW Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004;8(3):R122-R127.

18.

Rea RS , Donihi AC , Bobeck M. , et al. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health System Pharm. 2007;64(4):385-395.

19.

Clayton SB , Mazur JE , Condren S. , Hermayer KL , Strange C. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med. 2006;34(12):2974-2978.

20.

Goldberg PA , Siegel MD , Sherwin RS , et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-467.

21.

Taylor BE , Schallom ME , Sona CS , et al. Efficacy and safety of an insulin protocol in a surgical ICU . J Am Coll Surg. 2006; 202(1):1-9.

22.

Brunkorst FM , Kuhnt E. , Engel C. , et al. Intensive insulin therapy in patients with severe sepsis and septic shock is associated with an increased rate of hypoglycemia-results from a randomized multicenter study (VISEP). Infection. 2005;33(supp 1):19.

23.

Dellinger R. , Levy M. , Carlet J. , et al., and the International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine; Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36(1):296-327. Erratum in: Crit Care Med. 2008;36(4):1394-1396.

24.

Van den Berghe G. , Wouters PJ , Bouillon R. , et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-366.